Evidence map›Paper›PMID 34578969›Full record

Trial reportNutrients2021

The Effects of Korean Red Ginseng on Biological Aging and Antioxidant Capacity in Postmenopausal Women: A Double-Blind Randomized Controlled Study.

Tae-Ha Chung, Ji-Hye Kim, So-Young Seol, Yon-Ji Kim, Yong-Jae Lee

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05592093 (An RCT Study to Investigate the Effect of Korean Red Ginseng for Middle-aged and Elderly Sub-health Population on Anti-oxidation), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05592093 phase2 / phase3completednot on this mapstarted 2023, after this paper: background citation

An RCT Study to Investigate the Effect of Korean Red Ginseng for Middle-aged and Elderly Sub-health Population on Anti-oxidation

TypeinterventionalSponsorShanghai Jiao Tong University School of MedicineRan2023 to 2024Enrolled900ConditionsHealthy Ageing, Antioxidative StressArmsKorean red ginseng capsule (marketed product in Korea), Korean red ginseng capsule(placebo)
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. The beneficial potential of ginseng for menopause.Journal of ginseng research · 2024
    Review
  12. Brain plasticity and ginseng.Journal of ginseng research · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Frontiers in pharmacology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tae-Ha ChungDepartment of Family Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.ORCID 0000-0001-5873-3352
Ji-Hye KimDepartment of Health Promotion, Severance Check-Up, Yonsei University Health System, Seoul 03722, Korea.ORCID 0000-0002-5719-8180
So-Young SeolDepartment of Internal Medicine, Gangnam Severance Hospital Biomedical Research Center, Yonsei University College of Medicine, Seoul 06273, Korea.
Yon-Ji KimDepartment of Health Promotion, Severance Check-Up, Yonsei University Health System, Seoul 03722, Korea.ORCID 0000-0002-1127-3130
Yong-Jae LeeDepartment of Family Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Korea.ORCID 0000-0002-6697-476X

Funding

Korean Society of Ginseng 2018
6 · The paper itself

Abstract

Postmenopausal women are vulnerable to aging and oxidative stress due to reduced estrogen. Previous studies have shown that Korean red ginseng (KRG) has beneficial effects on aging and antioxidant capacity. Therefore, we evaluated the effects of KRG on biological aging and antioxidant capacity in postmenopausal women. This study conducted a double-blinded, placebo-controlled clinical trial. The participants were randomly administered KRG or a placebo, and the following metrics were measured: mitochondria DNA (mtDNA) copy number as an indicator of biological aging and, total antioxidant status (TAS) as a marker of antioxidant capacity. Clinical symptoms of fatigue, as measured by the fatigue severity scale, were assessed before and after KRG administration. There were 63 participants, of whom 33 received KRG and 30 received a placebo. The mtDNA copy number (KRG group: 1.58 ± 2.05, placebo group: 0.28 ± 2.36,

Indexed as

PostmenopauseAgedAgingAntioxidantsDNA, MitochondrialDouble-Blind MethodFemaleGinsenosidesHumansMiddle AgedPanaxPlacebosPlant ExtractsRepublic of KoreaAntioxidantsDNA, MitochondrialGinsenosidesPlacebosPlant Extractsantioxidant activitybiological agingfatigueKorean red ginsengpostmenopausal women

Identifiers

PMID34578969
PMCPMC8469655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.